Pre-transplant CRP–albumin ratio as a biomarker in patients receiving haploidentical allogeneic hematopoietic transplantation: Developing a novel DRCI-based nomogram
- 1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- 2Collaborative Innovation Center of Hematology, Huazhong University of Science and Technology, Wuhan, China
By Wang K, Jian X, Xu Z and Wang H (2023) Front. Immunol. 14:1128982. doi: 10.3389/fimmu.2023.1128982
In the published article, there was an error in affiliation 1. Instead of “Institute of Hematology, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China,”, it should be “Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China”.
The authors apologize for this error apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: HSCT, inflammation, nutrition, disease risk comorbidity index, CAR
Citation: Wang K, Jian X, Xu Z and Wang H (2023) Corrigendum: Pre-transplant CRP–albumin ratio as a biomarker in patients receiving haploidentical allogeneic hematopoietic transplantation: developing a novel DRCI-based nomogram. Front. Immunol. 14:1206392. doi: 10.3389/fimmu.2023.1206392
Received: 15 April 2023; Accepted: 21 April 2023;
Published: 02 May 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Wang, Jian, Xu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Huafang Wang, whf2019@hust.edu.cn